|
1
|
Dang CV: Links between metabolism and
cancer. Genes Dev. 26:877–890. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bensinger SJ and Christofk HR: New aspects
of the Warburg effect in cancer cell biology. Semin Cell Dev Biol.
23:352–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Graham NA, Tahmasian M, Kohli B,
Komisopoulou E, Zhu M, Vivanco I, Teitell MA, Wu H, Ribas A, Lo RS,
Mellinghoff IK, Mischel PS and Graeber TG: Glucose deprivation
activates a metabolic and signaling amplification loop leading to
cell death. Mol Syst Biol. 8:5892012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palorini R, Cammarata FP, Balestrieri C,
Monestiroli A, Vasso M, Gelfi C, Alberghina L and Chiaradonna F:
Glucose starvation induces cell death in K-ras-transformed cells by
interfering with the hexosamine biosynthesis pathway and activating
the unfolded protein response. Cell Death Dis. 4:e7322013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mendivil-Perez M, Jimenez-Del-Rio M and
Velez-Pardo C: Glucose starvation induces apoptosis in a model of
acute T leukemia dependent on caspase-3 and apoptosis-inducing
factor: a therapeutic strategy. Nutr Cancer. 65:99–109. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ganapathy V, Thangaraju M and Prasad PD:
Nutrient transporters in cancer: relevance to Warburg hypothesis
and beyond. Pharmacol Ther. 121:29–40. 2009. View Article : Google Scholar
|
|
7
|
Adekola K, Rosen ST and Shanmugam M:
Glucose transporters in cancer metabolism. Curr Opin Oncol.
24:650–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jóźwiak P and Lipińska A: The role of
glucose transporter 1 (GLUT1) in the diagnosis and therapy of
tumors. Postepy Hig Med Dosw. 66:165–174. 2012.(In Polish).
|
|
9
|
Szablewski L: Expression of glucose
transporters in cancers. Biochim Biophys Acta. 1835:164–169.
2013.
|
|
10
|
Calvo MB, Figueroa A, Pulido EG, Campelo
RG and Aparicio LA: Potential role of sugar transporters in cancer
and their relationship with anticancer therapy. Int J Endocrinol.
2010:pii: 205357. 2010.PubMed/NCBI
|
|
11
|
Mori Y, Tsukinoki K, Yasuda M, Miyazawa M,
Kaneko A and Watanabe Y: Glucose transporter type 1 expression are
associated with poor prognosis in patients with salivary gland
tumors. Oral Oncol. 43:563–569. 2007. View Article : Google Scholar
|
|
12
|
Chung FY, Huang MY, Yeh CS, Chang HJ,
Cheng TL, Yen LC, Wang JY and Lin SR: GLUT1 gene is a potential
hypoxic marker in colorectal cancer patients. BMC Cancer.
9:2412009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krzeslak A, Wojcik-Krowiranda K, Forma E,
Jozwiak P, Romanowicz H, Bienkiewicz A and Brys M: Expression of
GLUT1 and GLUT3 glucose transporters in endometrial and breast
cancers. Pathol Oncol Res. 18:721–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sasaki H, Shitara M, Yokota K, Hikosaka Y,
Moriyama S, Yano M and Fujii Y: Overexpression of GLUT1 correlates
with Kras mutations in lung carcinomas. Mol Med Rep. 5:599–602.
2012.
|
|
15
|
Cho H, Lee YS, Kim J, Chung JY and Kim JH:
Overexpression of glucose transporter-1 (GLUT-1) predicts poor
prognosis in epithelial ovarian cancer. Cancer Invest. 31:607–615.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jóźwiak P, Krześlak A, Pomorski L and
Lipińska A: Expression of hypoxia-related glucose transporters
GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid
lesions. Mol Med Rep. 6:601–606. 2012.
|
|
17
|
Monti E and Gariboldi MB: HIF-1 as a
target for cancer chemotherapy, chemosensitization and
chemoprevention. Curr Mol Pharmacol. 14:62–77. 2011. View Article : Google Scholar
|
|
18
|
Mills KT, Bellows CF, Hoffman AE, Kelly TN
and Gagliardi G: Diabetes mellitus and colorectal cancer prognosis:
a meta-analysis. Colon Rectum Dis. 56:1304–1319. 2013. View Article : Google Scholar
|
|
19
|
Zhu Z, Wang X, Shen Z, Lu Y, Zhong S and
Xu C: Risk of bladder cancer in patients with diabetes mellitus: an
updated meta-analysis of 36 observational studies. BMC Cancer.
13:3102013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yun J, Rago C, Cheong I, Pagliarini R,
Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S,
Zhou S, Diaz LA, Velculescu VE, Lengauer C, Kinzler KW, Vogelstein
B and Papadopoulos N: Glucose deprivation contributes to the
development of KRAS pathway mutations in tumor cells. Science.
325:1555–1559. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Andersen DK: Diabetes and cancer: placing
the association in perspective. Curr Opin Endocrinol Diabetes Obes.
20:81–86. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shikata K, Ninomiya T and Kiyohara Y:
Diabetes mellitus and cancer risk: review of the epidemiological
evidence. Cancer Sci. 104:9–14. 2013. View Article : Google Scholar
|
|
23
|
De Pergola G and Silvestris F: Obesity as
a major risk factor for cancer. J Obes. 2013:2915462013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li W, Ma Q, Liu J, Han L, Ma G, Liu H,
Shan T, Xie K and Wu E: Hyperglycemia as a mechanism of pancreatic
cancer metastasis. Front Biosci. 17:1761–1774. 2012. View Article : Google Scholar
|
|
25
|
Shih SR, Chiu WY, Chang TC and Tseng CH:
Diabetes and thyroid cancer risk: literature review. Exp Diabetes
Res. 2012:5782852012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamada K, Saito M, Matsuoka H and Inagaki
N: A real-time method of imaging glucose uptake in single, living
mammalian cells. Nat Protoc. 2:753–762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ren BF, Deng LF, Wang J, Zhu YP, Wei L and
Zhou Q: Hypoxia regulation of facilitated glucose transporter-1 and
glucose transporter-3 in mouse chondrocytes mediated by HIF-1α.
Joint Bone Spine. 75:176–181. 2008. View Article : Google Scholar
|
|
28
|
Lidgren A, Bergh A, Grankvist K, Rasmuson
T and Ljungberg B: Glucose transporter-1 expression in renal cell
carcinoma and its correlation with hypoxia inducible factor-1α. BJU
Int. 101:480–484. 2008.
|
|
29
|
Baumann MU, Zamudio S and Illsley NP:
Hypoxic upregulation of glucose transporters in BeWo
choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am
J Physiol Cell Physiol. 293:C477–C485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iida T, Yasuda M, Miyazawa M, Fujita M,
Osamura RY, Hirasawa T, Muramatsu T, Murakami M, Saito K and Mikami
M: Hypoxic status in ovarian serous and mucinous tumors:
relationship between histological characteristics and HIF-1α/GLUT-1
expression. Arch Gynecol Obstet. 277:539–546. 2008. View Article : Google Scholar
|
|
31
|
Yasuda M, Miyazawa M, Fujita M, Kajiwara
H, Iida T, Hirasawa T, Muramatsu T, Murakami M, Mikami M, Saitoh K,
Shimizu M, Takekoshi S and Osamura RY: Expression of hypoxia
inducible factor-1α (HIF-1α) and glucose transporter-1 (GLUT-1) in
ovarian adenocarcinomas: Difference in hypoxic status depending on
histological character. Oncol Rep. 19:111–116. 2008.
|
|
32
|
Liu Y, Li YM, Tian RF, Liu WP, Fei Z, Long
QF, Wang XA and Zhang X: The expression and significance of HIF-1α
and GLUT-3 in glioma. Brain Res. 1304:149–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu XH, Chen SP, Mao JY, Ji XX, Yao HT and
Zhou SH: Expression and significance of hypoxia-inducible factor-1α
and glucose transporter-1 in laryngeal carcinoma. Oncol Lett.
5:261–266. 2013.
|
|
34
|
Bos R, van Der Hoeven JJ, van Der Wall E,
van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL,
Hoekstra OS, Lammertsma AA and Molthoff CF: Biologic correlates of
18fluorodeoxyglucose uptake in human breast cancer
measured by positron emission tomography. J Clin Oncol. 20:379–387.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Flier JS, Mueckler MM, Usher P and Lodish
HF: Elevated levels of glucose transport and transporter messenger
RNA are induced by ras or src oncogenes. Science. 235:1492–1495.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Osthus RC, Shim H, Kim S, Li Q, Reddy R,
Mukherjee M, Xu Y, Wonsey D, Lee LA and Dang CV: Deregulation of
glucose transporter 1 and glycolytic gene expression by c-Myc. J
Biol Chem. 275:21797–21800. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang C, Liu J, Liang Y, Wu R, Zhao Y,
Hong X, Lin M, Yu H, Liu L, Levine AJ, Hu W and Feng Z:
Tumour-associated mutant p53 drives the Warburg effect. Nat Commun.
4:29352013.PubMed/NCBI
|
|
38
|
Elstrom RL, Bauer DE, Buzzai M, Karnauskas
R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and
Thompson CB: Akt stimulates aerobic glycolysis in cancer cells.
Cancer Res. 64:3892–3899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Viglietto G, Amodio N, Malanga D, Scrima M
and De Marco C: Contribution of PKB/AKT signaling to thyroid
cancer. Front Biosci. 16:1461–1487. 2011. View Article : Google Scholar
|
|
40
|
Cassinelli G, Zuco V, Gatti L, Lanzi C,
Zaffaroni N, Colombo D and Perego P: Targeting the Akt kinase to
modulate survival, invasiveness and drug resistance of cancer
cells. Curr Med Chem. 20:1923–1945. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gao M, Liang J, Lu Y, Guo H, German P, Bai
S, Jonasch E, Yang X, Mills GB and Ding Z: Site-specific activation
of AKT protects cells from death induced by glucose deprivation.
Oncogene. 33:745–755. 2014. View Article : Google Scholar
|
|
42
|
Priebe A, Tan L, Wahl H, Kueck A, He G,
Kwok R, Opipari A and Liu JR: Glucose deprivation activates AMPK
and induces cell death through modulation of Akt in ovarian cancer
cells. Gynecol Oncol. 122:389–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mathews EH, Stander BA, Joubert AM and
Liebenberg L: Tumor cell culture survival following glucose and
glutamine deprivation at typical physiological concentrations.
Nutrition. 30:218–227. 2014. View Article : Google Scholar
|
|
44
|
Young CD, Lewis AS, Rudolph MC, Ruehle MD,
Jackman MR, Yun UJ, Ilkun O, Pereira R, Abel ED and Anderson SM:
Modulation of glucose transporter 1 (GLUT1) expression levels
alters mouse mammary tumor cell growth in vitro and in vivo. PLoS
One. 6:e232052011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li S, Yang X, Wang P and Ran X: The
effects of GLUT1 on the survival of head and neck squamous cell
carcinoma. Cell Physiol Biochem. 32:624–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
